WELCOME MESSAGE
DEAR COLLEAGUES AND FRIENDS
Welcome to the inaugural Singapore Cell and Gene Therapy Pan Asia Summit 2024, held in partnership with the International Society for Cell and Gene Therapy. The conference will take place on the 19th and 20th of July 2024 in Singapore and will incorporate a pre-conference seminar and workshop on 18th July.
Jointly organised by the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), A*STAR’s Institute of Molecular and Cell Biology (IMCB), Regenerative Medicine Institute of Singapore (REMEDIS) and SingHealth Duke-NUS Cell Therapy Centre (SDCT), this summit will be Singapore’s largest cell and gene therapy (CGT) summit for 2024.
Themed “Enabling Cell and Gene Therapies for Asia”, the conference brings together CGT leaders in the region to showcase groundbreaking research, share practical insights into the curative roles of CGT in improving patients’ lives, as well as its impact for industrial development in Singapore and beyond.
The two-day programme will also offer ample opportunities for fruitful learning and networking and forging partnerships with clinicians, researchers, cell manufacturing experts and industry players. Delegates can look forward to a strong line-up of international and local speakers who will discuss a wide range of leading CGT topics with a focus on regenerative medicine and immunotherapy.
We have an exciting panel of speakers, including Professor Tak Wah Mak who discovered the T cell receptor and Professor Aude Chapuis, an expert in blood stem cell transplantation and immunotherapy.
On behalf of the Organising Committee, we look forward to welcoming you at the Singapore Cell and Gene Therapy Pan Asia Summit 2024 in Singapore.
Professor William Hwang
Senior Advisor, SingHealth
Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS)
A/Prof Danny Soon
Chief Executive Officer, Consortium for Clinical Research and Innovation, Singapore (CRIS)
Executive Director, Singapore Clinical Research Institute (SCRI)
Interim Executive Director, Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
A/Prof Loh Yuin Han Jonathan
Research Director, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR)
FEATURED SPEAKERS
A/Prof Aude G. Chapuis
Associate Professor, Translational Science and Therapeutics Division Fred Hutch Cancer Center,
The United States
Associate Professor, Department of Medicine Division of Hematology and Oncology, University of Washington
Dr Choi Dong-Ho
Department of Surgery, Hanyang University College of Medicine, South Korea
President, Korean Society for Stem Cell Research, South Korea
Prof Mak Tak Wah
Senior Scientist, Princess Margaret Cancer Centre, University Health Network, Canada
Director, The Campbell Family Institute for Breast Cancer Research
Professor, Departments of Immunology and Medical Biophysics, University of Toronto
Director, Centre of Oncology and Immunology, University of Hong Kong
Dr Mahendra S. Rao
Chief Scientific Officer,
Vita Therapeutics,
The United States
ORGANISED BY
SPONSORED BY
DIAMOND SPONSOR
PLATINUM SPONSORS
SILVER SPONSOR
BRONZE SPONSORS
ACADEMIC & START-UP SPONSOR
CONTACT US
Powered by
